Multinational comparison of new antidepressant use in older adults: a cohort study
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Objectives: We used an international pharmacosurveillance network to estimate the rate and characteristics of antidepressant use in older adults in countries with more conservative (UK) and liberal depression guidelines (Canada, USA). Setting: Electronic health records and population-based administrative data from six jurisdictions in four countries (UK, Taiwan, USA and Canada). Participants: A historical cohort of older adults (≥65 years) who had a new episode of antidepressant use between 2009 and 2014. Outcome measures: The age and sex-standardised cumulative incidence of new episodes of antidepressant use in older adults was measured. Descriptive statistics were used to compare the proportion of new users by the antidepressant prescribed, therapeutic class, potential treatment indication and country, as well as the characteristics of the first treatment episode (standardised daily doses, duration and changes). Results: The incidence of antidepressant use between 2009 and 2014 varied from 4.7% (Montreal and Quebec City) to 18.6% (Taiwan). Tricyclic antidepressants (TCAs) were the most commonly used class in the UK (48.8%) and Taiwan (52.4%) compared with selective serotonin reuptake inhibitors (SSRIs) in North American jurisdictions (42.3%–53.3%). Chronic pain was the most common potential treatment indication (41.2%–68.2%). Among users with chronic pain, TCAs were used most frequently in the UK and Taiwan (55.2%–60.4%), whereas SSRIs were used most frequently in North America (33.5%–46.4%). Treatment was longer (252–525 vs 169–437 days), standardised doses were higher (0.7–1.3 vs 0.5–1.0) and treatment was more likely to be changed (31%–46% vs 21%–34%) among patients with depression (9.1%–43%) than those with chronic pain. Conclusion: Antidepressant use in older adults varied 24-fold by country, with the UK, which has the most conservative treatment guidelines, being among the lowest. Chronic pain was the most common potential treatment indication. Evaluation of real-world risks of TCAs is a priority for future research, given high rates of use and the potential for increased toxicity in older adults because of potent anticholinergic effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., Gilron, I., Haanpää, M., Hansson, P., Jensen, T. S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70251-0 · Cited by 3,980
Data Resource Profile: Clinical Practice Research Datalink (CPRD)
Herrett, E., Gallagher, A. M., Bhaskaran, K., Forbes, H., Mathur, R., van Staa, T., & Smeeth, L. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv098 · Cited by 2,667 · cited 1×
“9% of the 64 million primary care population in the UK, and around 600 primary care practices.(29) Patients were included if their records met minimum quality standards and there were no gaps in registration.”
BackgroundBy the American Geriatrics Society 2015 Beers Criteria Update Expert Panel (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13702 · Cited by 2,609
Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies
Fayaz, A., Croft, P., Langford, R. M., Donaldson, L. J., & Jones, G. T. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010364 · Cited by 1,355
Kennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., Hasnain, M., Jollant, F., Levitt, A. J., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659417 · Cited by 1,181 · cited 1×
“Also, of interest, among patients with documented depression, antidepressant use in all countries followed current guidelines for depression management.(21) 24 52 53 Choice of first-line therapy was predominantly SSRIs and SNRIs.”
Lam, R. W., Kennedy, S. H., Grigoriadis, S., McIntyre, R. S., Milev, R., Ramasubbu, R., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.041 · Cited by 431
Mansfield, K. E., Sim, J., Jordan, J. L., & Jordan, K. P. (2016) · Pain · doi:10.1097/j.pain.0000000000000314 · Cited by 402
Systematic review of anticholinergic risk scales in older adults
Durán, C. E., Azermai, M., & Vander Stichele, R. H. (2013) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-013-1499-3 · Cited by 369
Self-report bias and underreporting of depression on the BDI-II
Hunt, M., Auriemma, J., & Cashaw, A. C. A. (2003) · Journal of Personality Assessment · doi:10.1207/s15327752jpa8001_10 · Cited by 301
Wong, J., Motulsky, A., Abrahamowicz, M., Eguale, T., Buckeridge, D. L., & Tamblyn, R. (2017) · BMJ · doi:10.1136/bmj.j603 · Cited by 221
Self-citation
Cited by
Saunders, R., Buckman, J. E. J., Stott, J., Leibowitz, J., Aguirre, E., John, A., Lewis, G., Cape, J., & Pilling, S. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.06.084 · Cited by 81
Amrein, M. A., Hengartner, M. P., Näpflin, M., Farcher, R., & Huber, C. A. (2023) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-023-03559-4 · Cited by 23
Self-therapy through bibliotherapy: A comprehensive review and content analysis for adults
Öztemiz, S., & Tekindal, M. (2025) · Information Development · doi:10.1177/02666669241309325 · Cited by 3
Metadata
- Authors
- Tamblyn, R., Bates, D. W., Buckeridge, D. L., Dixon, W., Forster, A. J., Girard, N., Haas, J., Habib, B., Kurteva, S., Li, J., & Sheppard, T.
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2019-05
- Volume
- 9
- Issue
- 5
- Pages
- e027663
- ISSN
- 2044-6055 (ISSN-L)
- OpenAlex
- W2946715802
- Cited by
- 76
- References
- 13
- FWCI
- 2.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Multinational comparison of new antidepressant use in older adults: a cohort study. https://app.cochat.ai/papers/10.1136/bmjopen-2018-027663
- The paper
- Tamblyn, R., Bates, D. W., Buckeridge, D. L., Dixon, W., Forster, A. J., Girard, N., Haas, J., Habib, B., Kurteva, S., Li, J., & Sheppard, T. (2019). Multinational comparison of new antidepressant use in older adults: a cohort study. BMJ Open. https://doi.org/10.1136/bmjopen-2018-027663
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.